 | Up a level |
Christen, Samuel E; Hermann, Laura; Bekka, Elias; Vonwyl, Celina; Hammann, Felix; van der Velpen, Vera; Eap, Chin B; Benowitz, Neal L; Haschke, Manuel; Liakoni, Evangelia (2024). Pharmacokinetics and pharmacodynamics of inhaled nicotine salt and free-base using an e-cigarette: A randomized crossover study. Nicotine & tobacco research, 26(10), pp. 1313-1321. Oxford University Press 10.1093/ntr/ntae074
Hermann, Laura; Schöning, Verena; Dräger, Sarah; Rentsch, Katharina; Moser, Stephan; Gürtler, Nicolas; Sendi, Parham; Osthoff, Michael; Hammann, Felix (2024). Population pharmacokinetics of flucloxacillin as intermittent bolus infusion in patients with Staphylococcus aureus bloodstream infection. The journal of antimicrobial chemotherapy, 79(8), pp. 2031-2039. Oxford University Press 10.1093/jac/dkae207
Kern, Charlotte; Müller, Pie; Chaccour, Carlos; Liechti, Matthias E; Hammann, Felix; Duthaler, Urs (2023). Pharmacokinetics of ivermectin metabolites and their activity against Anopheles stephensi mosquitoes. Malaria journal, 22(1), p. 194. BioMed Central 10.1186/s12936-023-04624-0
Chaccour, Carlos; Casellas, Aina; Hammann, Felix; Ruiz-Castillo, Paula; Nicolas, Patricia; Montaña, Julia; Mael, Mary; Selvaraj, Prashant; Duthaler, Urs; Mrema, Sigilbert; Kakolwa, Mwaka; Lyimo, Issa; Okumu, Fredros; Marathe, Achla; Schürch, Roger; Elobolobo, Eldo; Sacoor, Charfudin; Saute, Francisco; Xia, Kang; Jones, Caroline; ... (2023). BOHEMIA: Broad One Health Endectocide-based Malaria Intervention in Africa-a phase III cluster-randomized, open-label, clinical trial to study the safety and efficacy of ivermectin mass drug administration to reduce malaria transmission in two African settings. Trials, 24(1), p. 128. BioMed Central 10.1186/s13063-023-07098-2
Schöning, Verena; Liakoni, Evangelia; Baumgartner, Christine; Exadaktylos, Aristomenis K; Hautz, Wolf E; Atkinson, Andrew; Hammann, Felix (2022). Revalidating the prognostic COVID-19 severity assessment (COSA) score for variants of concern. Journal of translational medicine, 20(1), p. 427. BioMed Central 10.1186/s12967-022-03634-x
Schöning, Verena; Hammann, Felix (2022). Drug-Disease Severity and Target-Disease Severity Interaction Networks in COVID-19 Patients. Pharmaceutics, 14(9) MDPI 10.3390/pharmaceutics14091828
Buetler, Vanessa Alexandra; Agbariah, Nada; Schild, Deborah Pia; Liechti, Fabian D; Wieland, Anna; Andina, Nicola; Hammann, Felix; Kremer Hovinga, Johanna A (2022). Immune-Mediated Thrombotic Thrombocytopenic Purpura Following mRNA-Based COVID-19 Vaccine BNT162b2: Case Report and Mini-Review of the Literature. Frontiers in medicine, 9, p. 890661. Frontiers 10.3389/fmed.2022.890661
Schöning, Verena; Kern, Charlotte; Chaccour, Carlos; Hammann, Felix (2022). Effectiveness of Antiviral Therapy in Highly-Transmissible Variants of SARS-CoV-2: A Modeling and Simulation Study. Frontiers in Pharmacology, 13, p. 816429. Frontiers 10.3389/fphar.2022.816429
Drewe, Jürgen; Küsters, Ernst; Hammann, Felix; Kreuter, Matthias; Boss, Philipp; Schöning, Verena (2021). Modeling Structure-Activity Relationship of AMPK Activation. Molecules, 26(21) MDPI 10.3390/molecules26216508
Nicolas, Patricia; Kiuru, Caroline; Wagah, Martin G; Muturi, Martha; Duthaler, Urs; Hammann, Felix; Maia, Marta; Chaccour, Carlos (2021). Potential metabolic resistance mechanisms to ivermectin in Anopheles gambiae: a synergist bioassay study. Parasites & Vectors, 14(1), p. 172. BioMed Central 10.1186/s13071-021-04675-9
Scholz, Irene; Liakoni, Evangelia; Hammann, Felix; Grafinger, Katharina Elisabeth; Duthaler, Urs; Nagler, Michael; Krähenbühl, Stephan; Haschke, Manuel (2021). Effects of Hypericum perforatum (St John's wort) on the pharmacokinetics and pharmacodynamics of rivaroxaban in humans. British journal of clinical pharmacology, 87(3), pp. 1466-1474. Wiley-Blackwell 10.1111/bcp.14553
Duthaler, Urs; Weber, Michael; Hofer, Lorenz; Chaccour, Carlos; Maia, Marta; Müller, Pie; Krähenbühl, Stephan; Hammann, Felix (2021). The pharmacokinetics and drug-drug interactions of ivermectin in Aedes aegypti mosquitoes. PLoS pathogens, 17(3), e1009382. Public Library of Science 10.1371/journal.ppat.1009382
Schöning, Verena; Liakoni, Evangelia; Baumgartner, Christine; Exadaktylos, Aristomenis K.; Hautz, Wolf E.; Atkinson, Andrew; Hammann, Felix (2021). Development and validation of a prognostic COVID-19 severity assessment (COSA) score and machine learning models for patient triage at a tertiary hospital. Journal of translational medicine, 19(1), p. 56. BioMed Central 10.1186/s12967-021-02720-w
Chaccour, Carlos; Casellas, Aina; Blanco-Di Matteo, Andrés; Pineda, Iñigo; Fernandez-Montero, Alejandro; Ruiz-Castillo, Paula; Richardson, Mary-Ann; Rodríguez-Mateos, Mariano; Jordán-Iborra, Carlota; Brew, Joe; Carmona-Torre, Francisco; Giráldez, Miriam; Laso, Ester; Gabaldón-Figueira, Juan C; Dobaño, Carlota; Moncunill, Gemma; Yuste, José R; Del Pozo, Jose L; Rabinovich, N Regina; Schöning, Verena; ... (2021). The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial. EClinicalMedicine, 32, p. 100720. Elsevier 10.1016/j.eclinm.2020.100720
Kern, Charlotte; Schöning, Verena; Chaccour, Carlos; Hammann, Felix (2021). Modeling of SARS-CoV-2 treatment effects for informed drug repurposing. Frontiers in Pharmacology, 12 Frontiers 10.3389/fphar.2021.625678
Chaccour, Carlos; Abizanda, Gloria; Irigoyen-Barrio, Ángel; Casellas, Aina; Aldaz, Azucena; Martínez-Galán, Fernando; Hammann, Felix; Gil, Ana Gloria (2020). Nebulized ivermectin for COVID-19 and other respiratory diseases, a proof of concept, dose-ranging study in rats. Scientific reports, 10(1), p. 17073. 10.1038/s41598-020-74084-y
Chaccour, Carlos; Ruiz-Castillo, Paula; Richardson, Mary-Ann; Moncunill, Gemma; Casellas, Aina; Carmona-Torre, Francisco; Giráldez, Miriam; Mota, Juana Schwartz; Yuste, José Ramón; Azanza, José Ramón; Fernández, Miriam; Reina, Gabriel; Dobaño, Carlota; Brew, Joe; Sadaba, Belen; Hammann, Felix; Rabinovich, Regina (2020). The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial. Trials, 21(1), p. 498. BioMed Central 10.1186/s13063-020-04421-z
Chaccour, Carlos; Hammann, Felix; Ramón-García, Santiago; Rabinovich, N Regina (2020). Ivermectin and Novel Coronavirus Disease (COVID-19): Keeping Rigor in Times of Urgency. The American Journal of Tropical Medicine and Hygiene, 102(6), pp. 1156-1157. American Society of Tropical Medicine and Hygiene 10.4269/ajtmh.20-0271
Duthaler, Urs; Leisegang, Rory; Karlsson, Mats O; Krähenbühl, Stephan; Hammann, Felix (2020). The effect of food on the pharmacokinetics of oral ivermectin. The journal of antimicrobial chemotherapy, 75(2), pp. 438-440. Oxford University Press 10.1093/jac/dkz466
Duthaler, Urs; Suenderhauf, Claudia; Gaugler, Stefan; Vetter, Beatrice; Krähenbühl, Stephan; Hammann, Felix (2019). Development and validation of an LC-MS/MS method for the analysis of ivermectin in plasma, whole blood, and dried blood spots using a fully automatic extraction system. Journal of pharmaceutical and biomedical analysis, 172, pp. 18-25. Elsevier 10.1016/j.jpba.2019.04.007
Leuppi-Taegtmeyer, Anne; Duthaler, Urs; Hammann, Felix; Schmid, Yasmin; Dickenmann, Michael; Amico, Patricia; Jehle, Andreas W; Kalbermatter, Stefan; Lenherr, Christoph; Meyer Zu Schwabedissen, Henriette E; Haschke, Manuel Martin; Liechti, Matthias E; Krähenbühl, Stephan (2019). Pharmacokinetics of oxycodone/naloxone and its metabolites in patients with end-stage renal disease during and between haemodialysis sessions. Nephrology, dialysis, transplantation, 34(4), pp. 692-702. Oxford University Press 10.1093/ndt/gfy285
